AVEO Oncology
AVEO
#6581
Rank
HK$4.05 B
Marketcap
HK$116.78
Share price
0.00%
Change (1 day)
170.00%
Change (1 year)

Revenue for AVEO Oncology (AVEO)

Revenue in 2022 (TTM): HK$0.73 Billion

According to AVEO Oncology 's latest financial reports the company's current revenue (TTM ) is HK$0.73 Billion. In 2021 the company made a revenue of HK$0.32 Billion an increase over the revenue in the year 2020 that were of HK$46.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AVEO Oncology from 2009 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) HK$0.73 B124.04%
2021 HK$0.32 B606.8%
2020 HK$46.66 M-79.19%
2019 HK$0.22 B429.44%
2018 HK$42.35 M-28.47%
2017 HK$59.21 M203.62%
2016 HK$19.5 M-86.77%
2015 HK$0.14 B4.89%
2014 HK$0.14 B1302.08%
2013 HK$10.02 M-93.29%
2012 HK$0.14 B-88.32%
2011 HK$1.28 B268.21%
2010 HK$0.34 B116.45%
2009 HK$0.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$75.29 B 10,154.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$107.80 B 14,581.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$369.28 B 50,192.09%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$318.12 B 43,224.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$253.28 B 34,393.58%๐Ÿ‡บ๐Ÿ‡ธ USA